Community discussions

Boeing's health shows recovery signs but remains pressured by debt and losses. Simple breakdown:
Revenue (Latest Quarterly): Not available in real-time feed; 2025 full-year estimate: +28.9% YoY growth expected.
Net Income: Ongoing losses; Q3 2025 estimate contributes to annual EPS loss of $2.95.
Balance Sheet: High debt from past issues (e.g., 737 MAX); cash position stable but liabilities exceed assets in recent reports.
Value: Stock up 41.4% over past year, trading below 52-week high. Analysts see undervalued potential with production ramp-up.
Overall: Improving operations (e.g., 55 aircraft deliveries in October), but debt and losses keep it fragile. Health: Fair (recovering).
Catalyst & News-Driven Analysis: Events That Could Move the Price
Key real events from today/this week:
Positive: Delivered 55 aircraft in October (third-highest monthly total this year); UBS reiterates Buy rating with $280 target (up from current price).
Negative: U.S.-China trade tensions escalate—Trump threats on exports could hit China deliveries/deals; Turkish Airlines may switch 737 MAX orders to Airbus.
Other: Production ramp-up on 737 MAX announced; 777X launch delayed to 2027 (adds billions in costs).
Potential moves: Deliveries could push +5-10% short-term; trade risks -3-5%. No speculation—based on reports.
Market Sentiment & Macro: Overall Environment
Macro Environment: Broader market mixed. S&P 500 up slightly today (exact % not in feed; general uptrend). Global location set to New York—U.S. indices stable amid policy talks.
Investor Mood (Fear & Greed Index): 31 (Fear) as of Oct 16, 14:37 UTC—signals caution, below neutral (50).
As sooon as it turns up. Shorts ready to attack thus stocks. Relentless. That Turkish news isn’t even that big of a deal. They got a ton of deals daily in the pipelines. Crazy